Literature DB >> 33733692

The role of intraventricular antibiotic therapy in the treatment of ventriculo-peritoneal shunt infection in children.

Ayse Sahin1, Nazan Dalgic2, Mustafa Kilic3, Pinar Kirgiz3, M Kemal Kanik2, Ersoy Oz4, Adem Yilmaz3.   

Abstract

BACKGROUND: In this study, the effectiveness of intraventricular (IVT) antibiotic administration was evaluated in the treatment of ventriculo-peritoneal (VP) shunt infection by comparing patients who received only systemic antibiotic treatment with patients who received antibiotics added to systemic therapy by IVT route.
METHODS: From July 2009 to July 2019, 78 shunt infection episodes of 74 pediatric patients with bacterial growth in cerebrospinal fluid (CSF) culture who were treated with the diagnosis of VP shunt infection were retrospectively analyzed. The demographic data, clinical and laboratory parameters, antimicrobial management, and treatment outcomes of patients with VP shunt infections were recorded.
RESULTS: Thirty-eight of 78 shunt episodes received only systemic antibiotic treatment, and 40 had received IV plus IVT treatment. The mean age of the entire patient group was 16.7±21.3 months (range, 1 to 95 months). There was no significant difference between the two treatment groups in terms of mean age. The most common microorganism grown in CSF culture was coagulase-negative Staphylococcus. However, in the group that received IV plus IVT treatment, gram-negative bacteria were predominant (42.1% versus 20%), and this group had carbapenem-resistant and ESBL positive gram-negative bacteria growth. In the duration of CSF sterilization, hospital stay was statistically significantly shorter in the group receiving IV plus IVT treatment (p=0.000, p=0.000, respectively).
CONCLUSION: Our study shows that IVT administration of antibiotics shortens the duration of CSF sterilization, duration of antibiotic use, and the duration of hospital stay. For the treatment of VP shunt infection, the usage of IVT treatment in a particular group of a pediatric age is promising. However, further efforts should be done for supporting the current results by randomized controlled studies.

Entities:  

Keywords:  Children; Intraventricular; Shunt infections; Treatment

Year:  2021        PMID: 33733692     DOI: 10.1007/s00381-021-05116-9

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  20 in total

1.  Aggressive management of shunt infection: combined intravenous and intraventricular antibiotic therapy for twelve or less days.

Authors:  Hector E James; John S Bradley
Journal:  Pediatr Neurosurg       Date:  2008-01-24       Impact factor: 1.162

Review 2.  Cerebrospinal Fluid Shunting Complications in Children.

Authors:  Brian W Hanak; Robert H Bonow; Carolyn A Harris; Samuel R Browd
Journal:  Pediatr Neurosurg       Date:  2017-03-02       Impact factor: 1.162

3.  Risk factors and epidemiology of pediatric ventriculoperitoneal shunt infection.

Authors:  Amir Erps; Jonathan Roth; Shlomi Constantini; Liat Lerner-Geva; Galia Grisaru-Soen
Journal:  Pediatr Int       Date:  2018-12-10       Impact factor: 1.524

4.  Intraventricular and lumbar intrathecal administration of antibiotics in postneurosurgical patients with meningitis and/or ventriculitis in a serious clinical state.

Authors:  František Remeš; Robert Tomáš; Vlastimil Jindrák; Václav Vaniš; Michal Setlík
Journal:  J Neurosurg       Date:  2013-08-16       Impact factor: 5.115

Review 5.  Intra-cerebrospinal fluid antibiotics to treat central nervous system infections: A review and update.

Authors:  Oliver D Mrowczynski; Sara T Langan; Elias B Rizk
Journal:  Clin Neurol Neurosurg       Date:  2018-05-17       Impact factor: 1.876

6.  2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis.

Authors:  Allan R Tunkel; Rodrigo Hasbun; Adarsh Bhimraj; Karin Byers; Sheldon L Kaplan; W Michael Scheld; Diederik van de Beek; Thomas P Bleck; Hugh J L Garton; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2017-03-15       Impact factor: 9.079

Review 7.  Antimicrobial treatment options for neurosurgical ventricular shunt infections in children from 1993 to 2012: a systematic review.

Authors:  Richard J Drew; Theresa S Cole; Maggie K Lee; Stéphane Paulus; Conor L Mallucci; Andrew Riordan
Journal:  Childs Nerv Syst       Date:  2013-12-10       Impact factor: 1.475

8.  Reinfection after treatment of first cerebrospinal fluid shunt infection: a prospective observational cohort study.

Authors:  Tamara D Simon; Matthew P Kronman; Kathryn B Whitlock; Nancy E Gove; Nicole Mayer-Hamblett; Samuel R Browd; D Douglas Cochrane; Richard Holubkov; Abhaya V Kulkarni; Marcie Langley; David D Limbrick; Thomas G Luerssen; W Jerry Oakes; Jay Riva-Cambrin; Curtis Rozzelle; Chevis Shannon; Mandeep Tamber; John C Wellons; William E Whitehead; John R W Kestle
Journal:  J Neurosurg Pediatr       Date:  2018-02-02       Impact factor: 2.375

9.  Cerebrospinal fluid shunt survival and etiology of failures: a seven-year institutional experience.

Authors:  Matthew J McGirt; Jean-Christophe Leveque; John C Wellons; Alan T Villavicencio; John S Hopkins; Herbert E Fuchs; Timoth M George
Journal:  Pediatr Neurosurg       Date:  2002-05       Impact factor: 1.162

10.  Intrathecal or intraventricular therapy for post-neurosurgical Gram-negative meningitis: matched cohort study.

Authors:  B Shofty; A Neuberger; M E Naffaa; T Binawi; T Babitch; Z H Rappaport; M Zaaroor; G Sviri; M Paul
Journal:  Clin Microbiol Infect       Date:  2015-10-08       Impact factor: 8.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.